Logo image of BRED.CA

PUREBREAD BRANDS INC (BRED.CA) Stock Fundamental Analysis

TSX-V:BRED - TSX Venture Exchange - CA74624T2065 - Common Stock - Currency: CAD

0.06  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BRED. BRED was compared to 0 industry peers in the Unkown industry. BRED has a bad profitability rating. Also its financial health evaluation is rather negative. BRED has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BRED had negative earnings in the past year.
BRED had a positive operating cash flow in the past year.
BRED.CA Yearly Net Income VS EBIT VS OCF VS FCFBRED.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -26.26%
ROE N/A
ROIC N/A
ROA(3y)-72.5%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRED.CA Yearly ROA, ROE, ROICBRED.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -200K -400K -600K -800K

1.3 Margins

In the last couple of years the Gross Margin of BRED has declined.
BRED does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.64%
GM growth 5YN/A
BRED.CA Yearly Profit, Operating, Gross MarginsBRED.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

BRED does not have a ROIC to compare to the WACC, probably because it is not profitable.
BRED has more shares outstanding than it did 1 year ago.
BRED has a better debt/assets ratio than last year.
BRED.CA Yearly Shares OutstandingBRED.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
BRED.CA Yearly Total Debt VS Total AssetsBRED.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

BRED has an Altman-Z score of -2.01. This is a bad value and indicates that BRED is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of BRED is 10.66, which is on the high side as it means it would take BRED, 10.66 years of fcf income to pay off all of its debts.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.66
Altman-Z -2.01
ROIC/WACCN/A
WACC4%
BRED.CA Yearly LT Debt VS Equity VS FCFBRED.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

BRED has a Current Ratio of 0.06. This is a bad value and indicates that BRED is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.06 indicates that BRED may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
BRED.CA Yearly Current Assets VS Current LiabilitesBRED.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BRED have decreased by -1.60% in the last year.
BRED shows a strong growth in Revenue. In the last year, the Revenue has grown by 316.20%.
Measured over the past years, BRED shows a very strong growth in Revenue. The Revenue has been growing by 115.70% on average per year.
EPS 1Y (TTM)-1.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5%
Revenue 1Y (TTM)316.2%
Revenue growth 3Y115.7%
Revenue growth 5YN/A
Sales Q2Q%-9.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRED.CA Yearly Revenue VS EstimatesBRED.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BRED. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRED.CA Price Earnings VS Forward Price EarningsBRED.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 0.59
EV/EBITDA N/A
BRED.CA Per share dataBRED.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BRED does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PUREBREAD BRANDS INC

TSX-V:BRED (8/5/2025, 7:00:00 PM)

0.06

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners19.71%
Ins Owner ChangeN/A
Market Cap1.39M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF 0.59
P/OCF 4.73
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.1
FCFY169.95%
OCF(TTM)0.01
OCFY21.16%
SpS0.71
BVpS-0.33
TBVpS-0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.9%
FCFM 14.38%
ROA(3y)-72.5%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.64%
GM growth 5YN/A
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.66
Debt/EBITDA N/A
Cap/Depr 95.84%
Cap/Sales 12.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -2.01
F-Score4
WACC4%
ROIC/WACCN/A
Cap/Depr(3y)132.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)52.16%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)316.2%
Revenue growth 3Y115.7%
Revenue growth 5YN/A
Sales Q2Q%-9.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.24%
OCF growth 3YN/A
OCF growth 5YN/A